Table 2.
Clinical Outcomes
| Visual Acuity | Discomfort Severity & Frequency | Corneal Staining | Corneal Signs | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | |
| 1 | CF | 20/60 | 20/60 | 20/200 | 20/150 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 3 | 0 | 0 | 0 |
| 2 | 20/300 | 20/400 | N/Aa | 20/400 | 20/300 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 | 0 | 0 | 4 | 4 | 4 | 0 | 0 |
| 3 | 20/60 | 20/150a | 20/25 | 20/25 | 20/25 | 3 | 1 | 1 | 1 | 0 | 3 | 1 | 1 | 0 | 0 | 4 | 4 | 3 | 0 | 0 |
| 4 | 20/50 | 20/50 | 20/25 | 20/25 | 20/25 | 1 | 0 | 1 | 0 | 1 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| 5 | 20/100 | 20/70 | 20/20 | 20/20 | 20/20 | 3 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 3 |
| 6 | CF | HM | 20/400 | CF | CF | 2 | 0 | 0 | 1 | 1 | 3 | 3 | 0 | 2 | 1 | 4 | 4 | 0 | 4 | 4 |
| 7 | HMb | HMb | HMb | LPb | LPb | 1 | 0 | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 0 | 4 | 4 | 4 | 0 | 0 |
| 8 | 20/60 | CFa | 20/400 | 20/200 | 20/200 | 2 | 2 | 0 | 0 | 0 | 3 | 3 | 0 | 0 | 1 | 4 | 4 | 0 | 0 | 3 |
| 9 | HMb | HMb | HMb | HMb | HMb | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 4 | 0 | 0 | 0 |
| 10 | LP | LP | HM | 20/400 | 20/400 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 4 | 4 | 0 | 0 | 0 |
| 11 | 20/100 | 20/400a | 20/100 | 20/100 | 20/200 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| 12 | 20/50 | 20/100a | CFa | 20/60 | 20/40 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 1 | 0 | 1 | 4 | 0 | 3 | 0 | 0 |
| 13 | 20/100 | 20/400a | 20/50 | 20/60 | 20/20 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 0 | 0 | 0 | 4 | 4 | 0 | 0 | 0 |
Notes: aVision was obstructed from PKS, tarsorrhaphy, or thick ointment covering eye. bPoor visual potential due to severe advanced glaucoma.
Abbreviations: CF, counting fingers; HM, hand motion; LP, light perception; T0, Baseline; T1, Week 1; T2, Month 1; T3, Month 3; T4, Month 6.